Key result
Awareness of the risk-reducing effect of aspirin on hypertensive disorders of pregnancy was present in 51.9% of women with a history of the condition.
Why the study?
To elucidate patients' knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy.
Cross-Sectional (n=189)
Only about half of women with a history of hypertensive disorders of pregnancy are aware of the risk-reducing effect of aspirin for subsequent pregnancies, highlighting a need for improved counseling.
Suboptimal awareness supports enhanced counseling in high-risk women; leaves open whether education improves aspirin uptake and outcomes.
OBJECTIVE: To elucidate patients' knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). METHODS: A quantitative survey was performed including women who are members of the patient orgasnization Dutch HELLP Foundation due to a history of HDP. RESULTS: Awareness of the risk-reducing effect of aspirin on HDP was present in 51.9% of the 189 women. The majority was informed by their gynecologist (89.8%) and preferred to be informed by a gynecologist (79.4%), at the postpartum checkup (42.3%) or in the consecutive pregnancy (30.7%), both orally and written (62.4%). CONCLUSION: Half of the women with a history of HDP were aware of the risk-reducing effect of aspirin in a consecutive pregnancy.
No takes yet. Share an insight, caveat, or question.
Weg et al. (2020) conducted a cross-sectional in History of hypertensive disorders of pregnancy (HDP) (n=189). Knowledge of aspirin's risk-reducing effect was evaluated on Awareness of the risk-reducing effect of aspirin on HDP. Awareness of the risk-reducing effect of aspirin on hypertensive disorders of pregnancy was present in 51.9% of women with a history of the condition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: